Trials / Unknown
UnknownNCT04385004
Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU
Characterization of the Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in the Intensive Care Unit
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Renal damage in patients hospitalized for ARDS in the ICU can also be related to multiple causes including, but not limited to, the consequences of hemodynamic fluctuations in these patients or the use of nephrotoxic drugs responsible for acute post-ischemic or toxic tubular necrosis. Frequently observed abnormalities of cioagumation may also have a potential impact on renal structures, particularly glomerular capillaries. The researchers wish to characterize and phenotype the renal impairment of patients hospitalized in intensive care with tables of severe Covid19 infections in ARDS: clinical, biological and histological (by performing post-mortem biopsies). Translated with www.DeepL.com/Translator (free version)
Conditions
Timeline
- Start date
- 2020-04-27
- Primary completion
- 2020-07-01
- Completion
- 2020-07-01
- First posted
- 2020-05-12
- Last updated
- 2020-05-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04385004. Inclusion in this directory is not an endorsement.